Saccharomyces boulardii in a child with recurrent Clostridium difficile

被引：15
|
作者：
Ooi, Chee Y.
Dilley, Anthony V. [2 ]
Day, Andrew S. [1 ]
机构：
[1] Univ New S Wales, Sydney Childrens Hosp, Sch Womens & Childrens Hlth, Dept Gastroenterol, Randwick, NSW 2031, Australia
[2] Univ New S Wales, Dept Surg, Sydney, NSW, Australia
来源：
PEDIATRICS INTERNATIONAL | 2009年 / 51卷 / 01期
关键词：
Clostridium difficile infection; Hirschsprung's disease; probiotic; Saccharomyces boulardii; PLACEBO-CONTROLLED TRIAL; DISEASE; PATHOGENESIS; PREVENTION; DIARRHEA;
D O I：
10.1111/j.1442-200X.2008.02782.x
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：156 / 158
页数：3
相关论文
共 50 条
  • [31] Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat
    Izadnia, F
    Wong, CT
    Kocoshis, SA
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (09) : 2055 - 2060
  • [32] Brewer's Yeast and Saccharomyces boulardii Both Attenuate Clostridium difficile-Induced Colonic Secretion in the Rat
    Fariba Izadnia
    Catarina Tse Wong
    Samuel A. Kocoshis
    Digestive Diseases and Sciences, 1998, 43 : 2055 - 2060
  • [33] Use of prophylactic Saccharomyces boulardii to prevent Clostridium difficile infection in hospitalized patients: a controlled prospective intervention study
    Carstensen, Jeppe West
    Chehri, Mahtab
    Schonning, Kristian
    Rasmussen, Steen Christian
    Anhoj, Jacob
    Godtfredsen, Nina Skavlan
    Andersen, Christian Ostergaard
    Petersen, Andreas Munk
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (08) : 1431 - 1439
  • [34] Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in a Child
    Kahn, Stacy A.
    Young, Sona
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (12): : 1930 - 1931
  • [35] Recurrent Clostridium difficile diarrhoea
    Kyne, L
    Kelly, CP
    GUT, 2001, 49 (01) : 152 - 153
  • [36] Therapy for recurrent Clostridium difficile
    不详
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) : U4 - U4
  • [37] Recurrent Clostridium difficile enterocolitis
    Bergamin, B
    Hess, T
    Jost, R
    Ballmer, PE
    Imoberdorf, R
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 130 (44) : 1681 - 1684
  • [38] Saccharomyces boulardii protease inhibits Clostridium difficile toxin A and B-induced effects in human colonic mucosa.
    Castagliuolo, I
    Valenick, L
    Riegler, M
    LaMont, JT
    Pothoulakis, C
    GASTROENTEROLOGY, 1998, 114 (04) : A948 - A949
  • [39] RANDOMIZED PLACEBO-CONTROLLED TRIAL OF SACCHAROMYCES-BOULARDII IN COMBINATION WITH STANDARD ANTIBIOTICS FOR CLOSTRIDIUM-DIFFICILE DISEASE
    MCFARLAND, LV
    SURAWICZ, CM
    GREENBERG, RN
    FEKETY, R
    ELMER, GW
    MOYER, KA
    MELCHER, SA
    BOWEN, KE
    COX, JL
    NOORANI, Z
    HARRINGTON, G
    RUBIN, M
    GREENWALD, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (24): : 1913 - 1918
  • [40] EFFECT OF ORAL SACCHAROMYCES-BOULARDII TREATMENT ON THE ACTIVITY OF CLOSTRIDIUM-DIFFICILE TOXINS IN MOUSE DIGESTIVE-TRACT
    CORTHIER, G
    LUCAS, F
    JOUVERT, S
    CASTEX, F
    TOXICON, 1992, 30 (12) : 1583 - 1589
12345